| Q41653377 | A synthetic peptide mimic of plasma apolipoprotein E that binds the LDL receptor |
| Q36201407 | Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice |
| Q34497951 | Apolipoprotein E: From lipid transport to neurobiology |
| Q44158115 | Arterial hardening in mice |
| Q37388151 | Blunted feedback suppression of SREBP processing by dietary cholesterol in transgenic mice expressing sterol-resistant SCAP(D443N). |
| Q67937712 | Cyclosporine, low-density lipoprotein, and cholesterol |
| Q36531225 | Cytoplasmic sequence required for basolateral targeting of LDL receptor in livers of transgenic mice |
| Q43734161 | Developmental abnormalities in transgenic mice expressing a sialic acid-specific 9-O-acetylesterase |
| Q34263181 | Diet-induced hypercholesterolemia in mice: prevention by overexpression of LDL receptors |
| Q33645475 | Efficient expression of retroviral vector-transduced human low density lipoprotein (LDL) receptor in LDL receptor-deficient rabbit fibroblasts in vitro |
| Q28510584 | Endoglin is required for myogenic differentiation potential of neural crest stem cells |
| Q35526805 | Experimental and clinical applications of molecular cell biology in nutrition and metabolism |
| Q40905171 | Exploring pathogenetic mechanisms using transgenic animals |
| Q35205250 | From diet to DNA: dietary patterning of gene expression |
| Q40559434 | Genetic models of human vascular disease |
| Q54575442 | Hepatic lipid accumulation in apolipoprotein C-I-deficient mice is potentiated by cholesteryl ester transfer protein. |
| Q39883795 | Hepatitis B virus induces expression of cholesterol metabolism-related genes via TLR2 in HepG2 cells |
| Q29615235 | Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery |
| Q33832739 | Increased clearance of plasma cholesterol after injection of apolipoprotein E into Watanabe heritable hyperlipidemic rabbits |
| Q39559406 | Inflammatory stress exacerbates hepatic cholesterol accumulation via increasing cholesterol uptake and de novo synthesis |
| Q34258604 | Koch's postulates for cholesterol |
| Q40588222 | Lipoproteins and their functions |
| Q41063915 | Liver-directed gene transfer and application to therapy |
| Q42836644 | Low-density-lipoprotein receptors in different rabbit liver cells |
| Q35588973 | Lowering cholesterol, 1988. Rationale, mechanisms, and means |
| Q60045905 | Lucky, times ten: A career in Texas science |
| Q35788419 | Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency |
| Q40601689 | Molecular biology and gene transfer in atherosclerosis in the stenting era. |
| Q58136301 | Molecular genetics of familial hypercholesterolaemia: common and rare mutations of the low density lipoprotein receptor gene |
| Q34291227 | Multiplex gene regulation: a two-tiered approach to transgene regulation in transgenic mice |
| Q24306058 | Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol |
| Q36857781 | Overexpression of apolipoprotein E in transgenic mice: marked reduction in plasma lipoproteins except high density lipoprotein and resistance against diet-induced hypercholesterolemia |
| Q34250947 | Overexpression of human low density lipoprotein receptors leads to accelerated catabolism of Lp(a) lipoprotein in transgenic mice |
| Q30274556 | Overexpression of low-density lipoprotein receptor in the brain markedly inhibits amyloid deposition and increases extracellular A beta clearance |
| Q44509776 | Overexpression of sterol regulatory element-binding protein-1a in mouse adipose tissue produces adipocyte hypertrophy, increased fatty acid secretion, and fatty liver. |
| Q37360326 | Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a |
| Q41021318 | Plasma lipoprotein metabolism in transgenic mice overexpressing apolipoprotein E. Accelerated clearance of lipoproteins containing apolipoprotein B. |
| Q44317088 | Quantitative trait loci that determine lipoprotein cholesterol levels in DBA/2J and CAST/Ei inbred mice |
| Q24798892 | Rapid degradation of dominant-negative Rab27 proteins in vivo precludes their use in transgenic mouse models. |
| Q36434617 | Recent developments in the treatment of atherosclerosis |
| Q36649344 | Sequences containing the second-intron enhancer are essential for transcription of the human apolipoprotein B gene in the livers of transgenic mice |
| Q28585606 | Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure |
| Q33338471 | Spatial relational memory requires hippocampal adult neurogenesis |
| Q24297663 | Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor |
| Q40802362 | The biology of the artery wall in atherogenesis. |
| Q35604030 | The familial hypercholesterolemia (FH)-North Karelia mutation of the low density lipoprotein receptor gene deletes seven nucleotides of exon 6 and is a common cause of FH in Finland |
| Q89706215 | The novel llama-human chimeric antibody has potent effect in lowering LDL-c levels in hPCSK9 transgenic rats |
| Q36844564 | The use of transgenic animals to study the role of growth factors in endocrinology |
| Q36223333 | Tissue-specific sorting of the human LDL receptor in polarized epithelia of transgenic mice |
| Q40527453 | Transcriptional control of the human apolipoprotein B gene in cell culture and in transgenic animals. |
| Q69352129 | Transgenic animals |
| Q36525382 | Transgenic mouse models of lipoprotein metabolism and atherosclerosis |